{"id":"NCT01001832","sponsor":"Bristol-Myers Squibb","briefTitle":"Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients","officialTitle":"A Phase II/III, Multicenter, Randomized, Double-Blind, Double-Dummy Study to Assess Similarity of the Efficacy, Pharmacokinetics, Safety and Immunogenicity of Abatacept Administered Subcutaneously or Intravenously in Japanese Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-12","primaryCompletion":"2011-02","completion":"2012-10","firstPosted":"2009-10-27","resultsPosted":"2013-02-07","lastUpdate":"2014-02-06"},"enrollment":118,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Intravenous (IV) abatacept","otherNames":["BMS-188667"]},{"type":"DRUG","name":"Subcutaneous (SC) abatacept","otherNames":["BMS-188667"]}],"arms":[{"label":"Subcutaneous (SC) abatacept, 125 mg","type":"ACTIVE_COMPARATOR"},{"label":"Intravenous (IV) abatacept, 125 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy, pharmacokinetics, safety, and immunogenicity of abatacept after subcutaneous and intravenous administration in Japanese participants with active rheumatoid arthritis and inadequate response to methotrexate.","primaryOutcome":{"measure":"Percentage of Participants With an American College of Rheumatology (ACR) 20 Response at Day 169 in Short Term Period","timeFrame":"Day 169","effectByArm":[{"arm":"Subcutaneous (SC) Abatacept, 125 mg","deltaMin":91.5,"sd":null},{"arm":"Intravenous (IV) Abatacept, 125 mg","deltaMin":83.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":12},"locations":{"siteCount":33,"countries":["Japan"]},"refs":{"pmids":["25698370"],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":112},"commonTop":["Nasopharyngitis","Stomatitis","Alanine aminotransferase increased","Pharyngitis","Hypertension"]}}